| Description |
|---|
|
|
canakinumab
|
a human anti-interleukin-1beta monoclonal antibody for treatment of cryopyrin-associated periodic syndrome | Bioactivity details | MOA | |
|
rilonacept
|
an anti-arthritis agent derived from IL-1R and IL-1RAcP | Bioactivity details | MOA |